{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-022450","form_type":"8-K","ticker":"CRH","cik":"0000849395","company_name":"CRH PUBLIC LTD CO","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.138075+00:00","generated_at":"2026-06-02T04:29:13.327868+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CRH Q1 2024 net income $114M vs loss last year; reaffirms FY guidance","bullets":["Q1 net income $114M (EPS $0.16) vs net loss $31M (loss $0.05) in Q1 2023; revenue $6.5B +2%.","Adjusted EBITDA $445M +15% YoY; margin 6.8% up 80bps.","Completed $2.1B acquisition of Texas cement/readymix assets; expects $60M run-rate synergies by year three.","Agreed to acquire majority stake in Adbri (Australia) for $0.7B; transaction expected to close in 2024.","New quarterly dividend $0.35/share (+5% annualized) payable June 26; $0.3B share buyback tranche commenced."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-022450","json":"https://secwatch.observer/filing/0001628280-24-022450.json","markdown":"https://secwatch.observer/filing/0001628280-24-022450.md","text":"https://secwatch.observer/filing/0001628280-24-022450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849395/000162828024022450/0001628280-24-022450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849395/000162828024022450/crh-20240510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:29:13.327868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45eb163c539d031a85f77e4427ca2b2880d80090","claim":"CRH PUBLIC LTD CO reported the fiscal quarter ended March 31, 2024 results: revenue $6.5bn, net income $114m, EPS $0.16. Guidance reaffirmed.","evidence_excerpt":"shall be expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Q1 2024 Results Key Highlights Summary Financials Q1 2024 Change Total revenues $6.5bn +2% Net income 1 $114m 1 n/m 1 Net income margin 1.7% +220bps Adjusted EBITDA* $445m +15% Adjusted EBITDA margin* 6.8% +80bps EPS 1 $0.16 1 n/m 1 • Solid start to the year in","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849395/000162828024022450/0001628280-24-022450-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended March 31, 2024"},{"label":"Revenue","value":"$6.5bn"},{"label":"Net income","value":"$114m"},{"label":"EPS","value":"$0.16"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}